Press Release: European Medicines Agency to review third- and fourth-generation combined oral contraceptives

Author (Corporate)
Series Title
Series Details EMA/20410/2013 (28.01.13)
Publication Date 28/01/2013
Content Type

The European Medicines Agency (EMA), in January 2013, was aksed by France to review third- and fourth-generation combined oral contraceptives to determine whether there was a need to restrict the use of these medicines to women who could not take other combined oral contraceptives.

France made this request amid initiatives to reduce the use of third- and fourth-generation combined oral contraceptives by French women in favour of using second-generation oral contraceptives.

It is well established that combined contraceptives carry a very rare risk of venous thromboembolism (VTE or blood clots).

Source Link Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/01/news_detail_001700.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/20410/2013 (28.1.13): European Medicines Agency to review third- and fourth-generation combined oral contraceptives http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2013/01/WC500137933.pdf

Subject Categories
Countries / Regions ,